The diagnosis and management of chronic lung allograft dysfunction

GM Verleden, JMH Hendriks… - Current Opinion in …, 2024 - journals.lww.com
The diagnosis and management of chronic lung allograft dysfu... : Current Opinion in Pulmonary
Medicine The diagnosis and management of chronic lung allograft dysfunction : Current …

Association of positive pre-transplant angiotensin ii type 1 receptor antibodies with clinical outcomes in lung transplant recipients

BS Son, HJ Lee, WH Cho, MW So, JM Park… - Transplant …, 2023 - Elsevier
Introduction Autoantibodies against the angiotensin II type 1 receptor (AT1R-Ab) have been
previously associated with de novo donor-specific antibody (DSA) formation in lung …

Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction

K Mineura, S Tanaka, Y Goda, Y Terada… - American Journal of …, 2024 - Elsevier
Chronic lung allograft dysfunction (CLAD) remains one of the major limitations to long-term
survival after lung transplantation. We modified a murine model of CLAD and transplanted …

[HTML][HTML] Impact of Transient and Persistent Donor-Specific Antibodies in Lung Transplantation

S Auner, C Hillebrand, PM Boehm… - Transplant …, 2024 - frontierspartnerships.org
Lung transplantation (LuTx) is an established treatment for patients with end-stage lung
diseases, however, outcomes are limited by acute and chronic rejection. One aspect that …

Management of donor-specific antibodies in lung transplantation

W Brandon, C Dunn, S Bollineni, J Joerns… - Frontiers in …, 2023 - frontiersin.org
The formation of antibodies against donor human leukocyte antigens poses a challenging
problem both for donor selection as well as postoperative graft function in lung …

[HTML][HTML] Acute Rejection of the Lung Allograft: Phenotypes and Management

B Menachem, S Hanna, D Kulkarni, H Azfar Ali - OBM Transplantation, 2023 - lidsen.com
Abstract Treatment options for end stage lung diseases are limited to stabilizing lung failure,
decreasing disease progression, and symptom management, but significant reversal of lost …

Donor Specific Antibodies in Extracorporeal Membrane Oxygenation-Bridged Lung Transplant Recipients

LE Federico, JM Diamond, M Kamoun… - Annals of Thoracic …, 2024 - Elsevier
ABSTRACT BACKGROUND Extracorporeal membrane oxygenation (ECMO) is increasingly
used as a bridge to lung transplantation. Although other mechanical circulatory support …